Article

jdsupra.com on 2023-03-20 15:00

CMS Begins Implementation of the Inflation Reduction Act: Medicare Issues List of Drugs and Biologics Subject to Inflation Rebates

The Inflation Reduction Act of 2022 (Public Law 117-169) (the Act) contained an array of novel prescription drug provisions, which we described in our ...

Wilson Sonsini

Related news

CMS Issues Revised Guidance Implementing Medicare Inflation Rebates Under the Inflation Reduction Act jdsupra.com
United States
CMS and OIG Issue Guidance on Implementation of the Inflation Reduction Act jdsupra.com
CMS Issues First Guidance Regarding the Inflation Reduction Act jdsupra.com
CMS Issues Proposed Guidance on Inflation Rebates Under Medicare Part B jdsupra.com
The Inflation Reduction Act: Implementation of the Medicare Prescription Drug Inflation Rebates jdsupra.com
CMS Issues an Information Collection Request for the Drug Price Negotiation Process: Inflation Reduction Act Updates jdsupra.com
CMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates jdsupra.com
CMS Issues New Guidance on Medicare Drug Price Negotiation Program: Inflation Reduction Act Updates jdsupra.com
CMS Issues an Information Collection Request on Negotiation Data Elements: Inflation Reduction Act Updates jdsupra.com
Inflation Reduction Act May Accelerate Generic And Biosimilar Market Entry, But Questions Remain Around CMS Guidance Forbes
Inflation Reduction Act Favors Biologics Over Small Molecules: In The Long Term, This Could Partly Undermine Bill’s Effort To Contain Costs Forbes
Amitsoq
CMS Releases Its List of 27 Part B Rebatable Drugs for Q2 of 2023: Inflation Reduction Act Updates jdsupra.com
OIG Technical Assistance on Part B Inflation Rebates Implementation Barriers and CMS’ Proposed Solutions in Recent Part B Inflation Rebate Initial Guidance jdsupra.com
Maryland
As CMS Asks For The Public’s Feedback On Implementing The Inflation Reduction Act, Unresolved Issues Related To Drug Price Negotiations Remain Forbes
CMS Proposes Reimbursement Reduction for 340B Drugs jdsupra.com
The CMS List of Selected Drugs: Developing Effective Arguments for Pricing of Selected Drugs Under the Inflation Reduction Act of 2022 jdsupra.com
United States , Cong
CMS Seeks Stakeholder Feedback About Medicare Transaction Facilitator Services for the Medicare Drug Price Negotiation Program by November 13: Inflation Reduction Act Updates jdsupra.com
CMS Suspends Implementation and Enforcement of Vaccine Mandate jdsupra.com
District of Columbia
CMS Prioritizes Patient Care, Allows Flexibility with MACRA Implementation jdsupra.com
CMS to Host Call on Implementation of the IMPACT Act jdsupra.com